Results 231 to 240 of about 1,039,355 (265)
Some of the next articles are maybe not open access.
Biochemical disease-free survival following 125I prostate implantation
International Journal of Radiation Oncology*Biology*Physics, 1997To assess the 5-year clinical and biochemical results of ultrasound-guided permanent 125I brachytherapy in early adenocarcinoma of the prostate. Biochemical disease-free survival (BDFS) is reported, using PSA follow-up and is compared to the surgical and radiation therapy literature.From December 1988 through December 1993, ultrasound-guided ...
D C, Beyer, J B, Priestley
openaire +2 more sources
Improved three-year disease-free survival in osteogenic sarcoma
The Journal of Bone and Joint Surgery. British volume, 1982Of 41 consecutive patients with newly diagnosed osteogenic sarcoma admitted to the Children's Orthopedic Hospital and Medical Center in Seattle, Washington, between 1952 and 1977, 19 treated before 1973 did not receive adjunctive chemotherapy (histological group) whereas after 1972 22 have been so treated (chemotherapy group).
W A, Bleyer +10 more
openaire +2 more sources
Surveillance and Screening During Disease-Free Survival
2008After surgery for cancer of the spine, follow-up care to detect recurrence is an expected part of the overall postoperative care. Components of disease-free surveillance include periodic physical examinations, radiological studies, and blood work to follow or detect tumor markers.
Richard Placide +2 more
openaire +1 more source
Disease‐free survival and recurrence after resection of colorectal carcinoma
Journal of Surgical Oncology, 1981AbstractRecurrence Data From A Series Of 1, 315 Colorectal Cancer Patients Managed By One Surgeon With Potentially Curative Resection Are Presented. Complete Follow‐Up Information Was Available On 1, 287 (98%) Patients. At The Time Of The Last Recurrences, 164 And 232 Months For Rectal And Colonic Tumours Respectively, The Long‐Time Recurrence Rate Was
E, Pihl +4 more
openaire +2 more sources
Diminished Disease-Free Survival After Lobectomy: Screening Implications
Clinical Lung Cancer, 2015The aim of this study was to estimate the effect of lobectomy on life expectancy in healthy smokers and consider the implications for lung cancer screening.In a retrospective cohort study that provided a minimum of 15 years of follow-up, we analyzed lung cancer survival, all-cause survival, and fatality (1-survival) of 261 persons with stage I non ...
Jerome M, Reich +2 more
openaire +2 more sources
Long-term disease-free survival in immature teratoma of the ovary
Cancer, 1982Long-term follow-up on five patients with immature teratoma of the ovary with residual metastatic Grade 0 disease following chemotherapy is reported. All five patients are free of progressive disease 40–96 months following original diagnosis. The concept of ‘retroconversion’ following chemotherapy for immature teratoma of the ovary is reemphasized ...
P, Dara +3 more
openaire +2 more sources
Response, disease-free survival, and overall survival: What matters for whom?
European Surgery, 2010BACKGROUND: There is unanimous consent that the individualization of therapy is a necessary and rewarding way to direct anticancer treatment. METHODS: Review on aspects of anticancer therapy. RESULTS: This manuscript elucidates the different positions of those who are receiving anticancer therapy and those who are involved in providing health care ...
openaire +1 more source
Medical Oncology, 2014
Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability. Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and ...
Xiao-tian, Ye +4 more
openaire +2 more sources
Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability. Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and ...
Xiao-tian, Ye +4 more
openaire +2 more sources
An analysis of disease-free survival and overall survival in inflammatory breast cancer
2016OBJECTIVE: To examine if Inflammatory Breast Cancer (IBC) have worse disease-free and overall survival than non-Inflammatory Breast Cancer (non-IBC) patients. ? METHODS: Overall survival (OS) and disease-free survival (DFS) and locoregional control survival (LRC) were compared between IBC and non-Inflammatory Breast Cancer (non-IBC) Stage III patients.
openaire +1 more source
Metastatic Liver Tumors: The Path to Disease-Free Survival
Hematology/Oncology Clinics of North America, 2021openaire +3 more sources